SciELO - Scientific Electronic Library Online

 
vol.8 issue2 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Paraguaya de Reumatología

On-line version ISSN 2413-4341

Rev. parag. reumatol. vol.8 no.2 Asunción Dec. 2022

https://doi.org/10.18004/rpr/2022.08.02.101 

Carta al Editor

Refractory subacute cutaneous lupus

Lupus cutáneo subagudo refractario

1Medicine Government Medical Collage Srinagar, India.


Keywords: Subacute refractory cutaneous lupus; cliclofosfamide.

Dear Editor,

Subacute cutaneous lupus erythematosus erythematosus is a variant of cutaneous lupus erythematosus that can occur in photosensitive patients with anti-Ro anti-bodies 1,2.

This cutaneous complication of lupus is treated primarily with photoprotection and antimalarials. In more than half of the cases this therapeutic approach is usually sufficient. However, 25% of patients present refractory subacute cutaneous lupus that requires systemic immunosuppressive medication such as cyclophosphamide with variable efficacy and not free of side effects, so its indication is not routine2-4. We present the case of a patient with subacute lupus resistant to conventional therapy and requiring systemic immuno-suppressive therapy.

An 18-year male presented to outpatient clinic with papulosquamous rash over face hands and feet of three weeks duration and on examination and evaluation was diagnosed as systemic lupus erythematosus as patient was fulfilling 7 out of 11 ACR criteria5 (oral ulcers, cutaneous lupus/ malar rash, Alopecia, photosensitivity, leucopenia, ANA hep 2 Positive, DsDNA Positive) for SLE and had moderate disease flare with SLEDAI 136. Patient was put on 0.5mg/kg prednisolone, azathioprine and hydroxychloroquine, however the cutaneous lupus progressed and leucopenia persisted despite the immunosuppressants and deterioration of skin lesions (Figure1) .

The patient was started on IV antibiotic Piperacillin ta- zobactam in view of raw skin lesions of subacute cutaneous lupus which seemed infected and in addition had positive CRP and leukopenia suggestive of infection. After 72 hrs. of IV antibiotics high dose steroid equivalent to 1mg/kg of prednisolone was started and Cyclophosphamide 15mg/KG was given as infusion. The patient showed excellent results within 3 weeks of starting treatment with corticosteroids and cyclophos- phamide as shown in Figures 1, Figures 2 and Figure 3. This improvement was observed from the cutaneous and hematological point of view.

Figure 1 Day of admission. 

Figure 2 One week after cyclophosphamide. 

Figure 3 Two weeks after cyclophosphamide.  

BIBLIOGRAFÍA

Sontheimer D. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological and genetic findings. Autoimmun Rev. 2005; 4: 253-263. [ Links ]

Kuhn A, Ochsendorf F, Bonsmann G. Treatment of cutaneous lupus erythematosus. Lupus. 2010; 19:1125-1136. [ Links ]

Fabbri P, Cardinali C, Giomi B, Caproni M. Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol. 2003; 4: 449-465. [ Links ]

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum. 1997;40(9):1725. [ Links ]

Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288. [ Links ]

AUTHORS CONTRIBUTION:

0AHP, MK, MI : manuscript preparation.

CONFLICTS OF INTEREST:

1The authors declare no conflicts of interest

Received: July 17, 2022; Accepted: October 20, 2022

Autor para correspondencia: (A. Hussain Parrey) Correo electrónico:chogalpora@gmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License